S. N. |
Project Title |
Principal Investigator |
Funding Agency |
collaborating Institute |
Duration |
1. |
Etiology, risk factors and interactions of enteric infection and malnutrition and the consequences for the child health and development in Nepal ( Extended Study 37-60 months) |
Prof. Dr. Prakash S. Shrestha |
Bill and Melinda Gates foundation |
Walter Reed/ AFRIMS Research Unit Nepal |
Nov. 2015 to March 2017 completed |
2 |
Effect of vitamin B12 supplementation on growth and development among infants in Bhaktapur, Nepal Nepal ( Extention 36-70 months) |
Prof. Dr. Prakash S. Shrestha |
Thrasher Research Fund |
Centre for international Health, Bergen, Norway Regional Centre for child and Youth Mental Health and Child welfare, West ,sUni Research Health, NorwayInnlandet Hospital Trust, Lillehammer, Norway |
1st April 2015 to Feb. 2018 |
3. |
The long term effect of vit. B12 supplementation on growth and neurodevelopment among Nepalese children at 30and 47 months of age Extended follow ups of study no 2 ( Version 1.6, dated 15 March 2017) |
Prof. Dr. Laxman Shrestha |
Norwegian Research Council under centre of excellence scheme to the centre for Intervention Science in Maternal and Child Health(CISMAC) |
Norwegian Research Council under centre of excellence scheme to the centre for Intervention Science in Maternal and Child Health(CISMAC) at university of Bergen, Norway |
May 2017 to June 2019 |
4. |
Zinc as an adjunct for the treatment of very severe disease in infants younger than 2 months |
Prof. Sudha Basnet |
Norwegian Research Council under centre of excellence scheme to the centre for Intervention Science in Maternal and Child Health and Globvac |
Pediatric biology centre, translational health Science and Technology Institute, Faridabad Centre for international Health, Bergen, Norway Innlandet Hospital Trust, Lillehammer, Norway |
Feb. 2016 to Dec. 2018 |
5. |
Supplementation of vitamin B12 in pregnancy and postpartum o growth and neurodevelopment in early childhood; A Randomised, placebo Controlled trial among pregnant women in Bhaktapur, nepal |
Prof. Dr. Laxman Shrestha |
CISMAC |
Centre for international Health, Bergen, Norway Innlandet Hospital Trust, Lillehammer, Norway |
April 2016 to June 2019 |
6. |
Global excellence in COPD: implementation of COPD Case Finding and self-management action plans in low and middle income countries |
Prof. Dr. Laxman Shrestha and prof. Dr. Kabir Nath Yogi |
Medical Research Council Gower Street, London UK, WC1E 6BT |
University College London, UKJohns Hopkins University USA |
Oct. 2017 to August 2019 |
7. |
Cross-sectional study to assess persistence of immunity conferred by a single IPV dose administered in EPI routine immunisation schedule |
Prof. Dr. Laxman Shrestha |
Centre for Disease Control, Atlanta, USA |
Centre for Disease Control, Atlanta, USA |
Feb 2018 to July 2018 |